India Inflammatory Disease Treatment Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the India Inflammatory Disease Treatment Market was valued at USD 61.0 million in 2025 and is projected to reach USD 87.56 million by 2032, growing at a CAGR of approximately 5.3% during 2026–2032.
India Inflammatory Disease Treatment Market Highlights
| Report Metric | Details |
| Report Name | India Inflammatory Disease Treatment Market |
| Market Size 2025 | USD 61.0 million |
| Market Size 2032 | USD 87.56 million |
| Absolute Growth 2025–2032 | USD 26.56 million |
| CAGR 2026–2032 | 5.3% |
| Peak Annual Growth | 7.6% in 2029 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Treatment Type, 2025 | Oral Medications (50% share) |
| Leading Delivery Mode, 2025 | Daily Dose (43% share) |
| Leading Patient Age Group, 2025 | Adults (37% share) |
| Leading Distribution Channel, 2025 | Online Pharmacies (38% share) |
| Fastest-Growing Treatment Type | Injectable Biologics (7.1% CAGR) |
| Fastest-Growing Delivery Mode | Monthly Injection (7.5% CAGR) |
| Fastest-Growing Patient Age Group | Elderly (7.3% CAGR) |
| Fastest-Growing Distribution Channel | Rheumatology Clinics (7.4% CAGR) |
| Growing Sector | Rheumatology Clinics |
| Key End Users | Online Pharmacies, Rheumatology Clinics, Health & Wellness Centers, Multispecialty Hospitals |
India Inflammatory Disease Treatment Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
The following table presents the estimated annual growth rate for each year together with the principal factor influencing market performance.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 3.0 | The market showed steady growth with increasing patient awareness and treatment options from the National Health Mission. |
| 2023 | 3.6 | Demand rose due to the successful implementation of the National Health Mission, improving treatment access. |
| 2024 | 5.3 | The market grew faster as more patients sought treatment for chronic conditions amid rising awareness from the Rheumatology Awareness Program. |
| 2025 | 4.7 | Growth slowed as patient adherence challenges affected treatment schedules and outcomes. |
| 2026 | 4.2 | A further slowdown is expected as regulatory hurdles delay new treatment approvals. |
| 2027 | 6.0 | Demand is projected to increase again with a rise in the use of injectable biologics among chronic patients. |
| 2028 | 4.1 | Growth is anticipated to slow as the market adjusts to the previous year's surge in treatment options. |
| 2029 | 7.6 | A peak in growth is expected as awareness campaigns reach more patients through the Rheumatology Awareness Program. |
| 2030 | 6.3 | The market will see a slowdown as competition increases among treatment providers in urban areas. |
| 2031 | 5.6 | Growth will continue to slow, reflecting market maturation and evolving patient needs for effective therapies. |
| 2032 | 3.4 | A further slowdown is expected as the market stabilises at a new level, focusing on patient adherence. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
India Inflammatory Disease Treatment Market Synopsis
Inflammatory Disease Treatment in India encompasses various therapeutic approaches aimed at managing conditions like arthritis and autoimmune disorders. This includes medications, biologics, and lifestyle modifications. The India Inflammatory Disease Treatment Market is growing due to rising patient numbers and government initiatives. Approximately 1.4 million patients are diagnosed with rheumatoid arthritis, driving demand for effective treatments. The National Health Mission and the 'Ayushman Bharat' scheme are key factors supporting access to these treatments.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Increasing patient awareness and access to healthcare services | Driver | High | Oral Medications |
| Rising usage of injectable biologics for severe cases | Driver | High | Injectable Biologics |
| Expansion of rheumatology clinics in urban areas | Opportunity | Medium | Rheumatology Clinics |
| Growing online pharmacy sales for convenience | Opportunity | Medium | Online Pharmacies |
| Limited access to advanced treatment options in rural areas | Restraint | High | Injectable Biologics |
| High cost of biologics limiting patient access | Restraint | Medium | Oral Medications |
| Challenges in patient adherence to treatment regimens | Challenge | High | Daily Dose |
| Competition among treatment providers affecting pricing | Challenge | Medium | Multispecialty Hospitals |
Evaluation of Drivers in India Inflammatory Disease Treatment Market (2026–2032)
The main growth drivers and the segments they affect most are set out below.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Growing patient population diagnosed with rheumatoid arthritis | Oral Medications | Approximately 1.4 million patients in India require ongoing treatment. |
| Increased adoption of biologics for severe inflammatory cases | Injectable Biologics | Usage has risen by 25% in the past year among severe cases. |
| Expansion of healthcare infrastructure in metropolitan areas | Rheumatology Clinics | Over 200 clinics established in urban areas to cater to rising demand. |
| Rising preference for convenient medication access through online platforms | Online Pharmacies | Online pharmacies account for 38% of the distribution channel in 2025. |
| Integration of lifestyle therapy into treatment plans | Lifestyle Therapy | 30% of clinics are incorporating lifestyle programs for chronic patients. |
Market growth in India for Inflammatory Disease Treatment rests on increasing patient numbers and expanding healthcare access. The establishment of over 200 rheumatology clinics in urban areas improves service availability. Injectable biologics usage has risen by 25%, creating substantial demand for advanced therapies. Online pharmacies, accounting for 38% of the distribution channel, provide convenient access to medications.
Evaluation of Restraints in India Inflammatory Disease Treatment Market
The key brakes on demand, and where they bite hardest, are shown below.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Limited access to advanced treatments in rural areas | Injectable Biologics | Patients in rural regions often lack access to specialized care, affecting treatment uptake and leading to lower patient outcomes. |
| High costs associated with biologic therapies | Oral Medications | The average cost of biologics can deter patients from seeking necessary treatments, limiting their access to effective therapies. |
| Patient adherence challenges due to complex regimens | Daily Dose | Many patients struggle to maintain consistent treatment schedules, impacting outcomes and prolonging recovery times. |
| Regulatory hurdles for new treatment approvals | Injectable Biologics | Lengthy approval processes delay access to new therapies for patients, hindering timely treatment. |
| Competition among treatment providers leading to pricing pressures | Multispecialty Hospitals | Increased competition may reduce profitability for providers, affecting service quality and availability. |
India Inflammatory Disease Treatment Market Challenges
The India Inflammatory Disease Treatment market faces a few practical problems, with the first being outdated technology in treatment facilities. Many hospitals rely on traditional methods, which limits therapy effectiveness and prolongs patient recovery times, leading to average treatment durations of 6-12 months for patients. Rising costs of advanced biologics, which have seen a 25% increase in usage, further strain budgets for healthcare providers, forcing them to allocate more funds for fewer patients. A shortage of trained professionals in rheumatology clinics hampers timely care delivery, resulting in patient visit frequencies exceeding monthly expectations for many buyers.
Trends in the India Inflammatory Disease Treatment Market
Several trends are reshaping the India Inflammatory Disease Treatment Market; the most important are set out below.
- Shift towards Injectable Biologics for Severe Cases: The trend towards injectable biologics for severe inflammatory conditions began in 2022, driven by their effectiveness. In 2023, usage increased by 25%, providing patients with advanced treatment options.
- Growing Integration of Lifestyle Therapy: Since 2021, there has been a notable shift towards integrating lifestyle therapy into treatment plans. Approximately 30% of clinics now offer these programs, improving patient outcomes and satisfaction.
- Rise of Online Pharmacies for Medication Access: The rise of online pharmacies in India has transformed medication access since 2020. By 2025, they are projected to account for 38% of the distribution channel, making treatments more accessible.
- Expansion of Rheumatology Clinics in Urban Areas: The establishment of rheumatology clinics surged after 2020, with over 200 clinics now serving urban populations. This expansion improves access to specialised care for inflammatory disease patients.
Investment Opportunities in the India Inflammatory Disease Treatment Market
Below are the investment opportunities with the strongest case in the India Inflammatory Disease Treatment Market.
- Partner with Local Clinics for Treatment Access: Now is the time to collaborate with urban rheumatology clinics, which have seen considerable growth. With over 200 clinics established, partnerships can enhance treatment access for patients, improving health outcomes.
- Supply Injectable Biologics for Severe Cases: There is a pressing need for injectable biologics as usage has risen by 25%. Focusing on this product type can meet the demand from healthcare providers in metropolitan areas, ensuring better patient care.
- Invest in Online Pharmacy Platforms: The current growth of online pharmacies presents an opportunity to invest in digital platforms. By 2025, they are expected to capture 38% of the distribution channel, appealing to tech-savvy consumers seeking convenience.
- Expand Lifestyle Therapy Programs in Clinics: With 30% of clinics integrating lifestyle therapy, now is the time to supply related programs. This trend can improve patient outcomes and attract more healthcare providers, enhancing overall treatment effectiveness.
Government Initiatives in the India Inflammatory Disease Treatment Market
The National Health Policy 2020 prioritises addressing chronic inflammatory diseases as a public health issue. This framework has guided the government's initiatives to improve healthcare access for patients. The National Health Mission, launched in 2020, aims to increase treatment accessibility, focusing on inflammatory diseases. Additionally, the 'Rheumatology Awareness Program' initiated in 2022 has educated the public on managing these conditions. These measures collectively enhance treatment access for patients across India.
In 2023, the Indian government allocated ₹500 crores for the National Health Mission to support healthcare initiatives. The Ministry of Health oversees this funding, ensuring that resources are directed towards improving treatment access and awareness for chronic disease patients. The 'Ayushman Bharat' scheme, updated in 2021, provides coverage for treatments related to inflammatory diseases for low-income families, further enhancing access to necessary therapies.
Future Insight of the India Inflammatory Disease Treatment Market
The India Inflammatory Disease Treatment market is projected to evolve significantly by 2032, driven by several key factors. The launch of the 'Ayushman Bharat' scheme will improve healthcare access for chronic patients, increasing treatment availability across various regions. Increased funding of ₹500 crores for the National Health Mission will support awareness and treatment initiatives. The rise of health and wellness centres will enhance lifestyle therapy offerings, while the integration of physiotherapy as a complementary approach will improve patient outcomes, benefiting both buyers and suppliers.
Market Segmentation Analysis
Each segment group is reviewed below, with the leader by share and the fastest grower by CAGR.
By Treatment Type – Oral Medications Dominated, Injectable Biologics Expected to Grow Fastest
According to Shubham Deep, Research Manager at 6Wresearch, Oral Medications accounted for a 50% market share by treatment type in 2025. Oral medications dominate the market share as they are the first line of treatment for managing inflammation in chronic conditions like rheumatoid arthritis, which affects around 1.4 million patients in India. Their widespread prescription by healthcare professionals ensures consistent demand and a robust installed base. The quickest growth will come from Injectable Biologics, forecast to expand at a CAGR of 7.1% between 2026 and 2032. Injectable biologics are experiencing significant growth, with a 25% increase in usage among severe cases last year, reflecting a shift towards more effective treatment options for complex inflammatory diseases. As oral medications continue to thrive, the rise of biologics will further enhance the overall treatment landscape. Suppliers must ensure a balanced portfolio of oral medications and injectable biologics to meet the diverse needs of patients in the inflammatory disease treatment market.
By Delivery Mode – Daily Dose Dominated, Monthly Injection Expected to Grow Fastest
With a 43% revenue share in 2025, Daily Dose was the largest delivery mode category. Daily dose regimens are the standard for chronic patients, ensuring consistent management of inflammatory diseases. This approach aligns with the average patient visit frequency of once a month, reinforcing the need for reliable daily treatments. Over 2026–2032, Monthly Injection is expected to post the fastest growth, at a CAGR of 7.5%. Monthly injections are gaining traction as they offer convenience for patients using biologics, reducing the frequency of administration. This trend indicates that daily dose treatments will need to adapt to maintain their market share amidst changing preferences. Buyers may benefit from exploring options that combine daily doses with the convenience of monthly injections.
By Patient Age Group – Adults Dominated, Elderly Expected to Grow Fastest
Adults took a 37% share of patient age group in 2025, more than any other category. Adults constitute the largest segment of patients seeking treatment for inflammatory diseases, reflecting the majority demographic affected by these conditions. The average onset age of around 40 years underscores the importance of targeted therapies for this age group. Elderly is set to record the highest CAGR in this split, 7.3% over 2026–2032. The elderly population is emerging as the fastest-growing segment, driven by a higher prevalence of inflammatory conditions among older individuals. As the adult demographic continues to expand, the elderly will likely increase their market share, necessitating tailored treatment strategies. Suppliers should explore the development of age-specific treatment options to effectively serve the growing elderly population.
By Distribution Channel – Online Pharmacies Dominated, Rheumatology Clinics Expected to Grow Fastest
In 2025, Online Pharmacies led the distribution channel split with a 38% share. Online pharmacies lead the distribution channel, offering patients across India convenient access to a wide range of medications. This channel's growth is driven by the increasing adoption of digital health solutions, making it easier for patients to obtain necessary treatments. Rheumatology Clinics are projected to grow fastest, at a CAGR of 7.4% during 2026–2032. Rheumatology clinics are rapidly emerging as the fastest-growing distribution channel, providing specialised care for inflammatory disease patients. As online pharmacies expand, rheumatology clinics must adapt and enhance their offerings to maintain their competitive edge in the market. Suppliers should focus on building strong relationships with both online pharmacies and rheumatology clinics to optimise their distribution strategies and reach a broader patient base.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- India Inflammatory Disease Treatment Market Outlook
- Market Size of India Inflammatory Disease Treatment Market, 2025
- Forecast of India Inflammatory Disease Treatment Market, 2032
- Historical Data and Forecast of India Inflammatory Disease Treatment Revenues & Volume for the Period 2022 - 2032F
- India Inflammatory Disease Treatment Market Trend Evolution
- India Inflammatory Disease Treatment Market Drivers and Challenges
- India Inflammatory Disease Treatment Price Trends
- India Inflammatory Disease Treatment Porter's Five Forces
- India Inflammatory Disease Treatment Industry Life Cycle
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Treatment Type for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Oral Medications for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Injectable Biologics for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Lifestyle Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Surgical Interventions for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Delivery Mode for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Daily Dose for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Monthly Injection for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Diet / Physiotherapy for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Colon / Joint Surgery for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Patient Age Group for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Adults for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Elderly for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Chronic Cases for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Severe Complications for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Distribution Channel for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Online Pharmacies for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Rheumatology Clinics for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Health & Wellness Centers for the Period 2022 - 2032F
- Historical Data and Forecast of India Inflammatory Disease Treatment Market Revenues & Volume By Multispecialty Hospitals for the Period 2022 - 2032F
- India Inflammatory Disease Treatment Import Export Trade Statistics
- Market Opportunity Assessment By Treatment Type
- Market Opportunity Assessment By Delivery Mode
- Market Opportunity Assessment By Patient Age Group
- Market Opportunity Assessment By Distribution Channel
- India Inflammatory Disease Treatment Top Companies Market Share
- India Inflammatory Disease Treatment Competitive Benchmarking By Technical and Operational Parameters
- India Inflammatory Disease Treatment Company Profiles
- India Inflammatory Disease Treatment Key Strategic Recommendations
Market Covered
This report examines the market across the segments below.
By Treatment Type
- Oral Medications
- Injectable Biologics
- Lifestyle Therapy
- Surgical Interventions
By Delivery Mode
- Daily Dose
- Monthly Injection
- Diet / Physiotherapy
- Colon / Joint Surgery
By Patient Age Group
- Adults
- Elderly
- Chronic Cases
- Severe Complications
By Distribution Channel
- Online Pharmacies
- Rheumatology Clinics
- Health & Wellness Centers
- Multispecialty Hospitals
